User login
Article Type
Changed
Display Headline
The MORE Trial: Focusing on the Treatment of Moderate to Moderately Severe Acne
Sponsor
Supported by a restricted educational grant from Galderma Laboratories, LP.
Article PDF
Issue
Cutis - 78(1)
Publications
Page Number
1-40
Legacy Keywords
Jonathan S. Weiss, James L. Campbell, Jr, Linda Stein Gold, John E. Wolf, Jr, Fran Cook-Bolden, Zoe D. Draelos, Acne, vulgaris, dermatology, adapalene gel 0.1%, oily skin, facial cleanser, National Ambulatory Medical Care Survey, isotretinoin cream 0.05%, Measuring Acne Outcomes Real-World Trial, MORE, lesions, inflammatory, SAS, erythema, peeling, dryness, burning, propionibacterium, retinoids, Global Alliance to Improve Outcomes in Acne, tazarotene, benzoyl peroxide, transepidermal water loss, TEWL
Sections
Article PDF
Article PDF
Sponsor
Supported by a restricted educational grant from Galderma Laboratories, LP.
Sponsor
Supported by a restricted educational grant from Galderma Laboratories, LP.
Issue
Cutis - 78(1)
Issue
Cutis - 78(1)
Page Number
1-40
Page Number
1-40
Publications
Publications
Article Type
Display Headline
The MORE Trial: Focusing on the Treatment of Moderate to Moderately Severe Acne
Display Headline
The MORE Trial: Focusing on the Treatment of Moderate to Moderately Severe Acne
Legacy Keywords
Jonathan S. Weiss, James L. Campbell, Jr, Linda Stein Gold, John E. Wolf, Jr, Fran Cook-Bolden, Zoe D. Draelos, Acne, vulgaris, dermatology, adapalene gel 0.1%, oily skin, facial cleanser, National Ambulatory Medical Care Survey, isotretinoin cream 0.05%, Measuring Acne Outcomes Real-World Trial, MORE, lesions, inflammatory, SAS, erythema, peeling, dryness, burning, propionibacterium, retinoids, Global Alliance to Improve Outcomes in Acne, tazarotene, benzoyl peroxide, transepidermal water loss, TEWL
Legacy Keywords
Jonathan S. Weiss, James L. Campbell, Jr, Linda Stein Gold, John E. Wolf, Jr, Fran Cook-Bolden, Zoe D. Draelos, Acne, vulgaris, dermatology, adapalene gel 0.1%, oily skin, facial cleanser, National Ambulatory Medical Care Survey, isotretinoin cream 0.05%, Measuring Acne Outcomes Real-World Trial, MORE, lesions, inflammatory, SAS, erythema, peeling, dryness, burning, propionibacterium, retinoids, Global Alliance to Improve Outcomes in Acne, tazarotene, benzoyl peroxide, transepidermal water loss, TEWL
Sections
Citation Override
Cutis. 2006;78(suppl 1):1-40.
PURLs Copyright
Disallow All Ads
Alternative CME
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica
Article PDF Media
Document